Comparison of Insulins (United States)
Click HERE to access the Canadian version of this resource.
This chart compares insulins in regard to onset, duration, and cost. It also provides information on route of administration, stability of in-use products at room temperature, and place in therapy. Other resources pertaining to insulin include our charts, How to Switch Insulin Products and Tips to Improve Insulin Safety.
--Information in this chart is from US product information a unless otherwise specified.--
Related Articles
- Focus on Lifestyle and Insulin for Gestational Diabetes
- Understand Why Semglee Will Be “Interchangeable” With Lantus
- Compare Lyumjev and Semglee to Other Insulins
- Don't Buy Into Marketing That Toujeo Max SoloStar Will Save Money
- Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)
- Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative
- Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes
- Think of Most Concentrated Insulins as "Me-Toos" of the Original Forms
- Don't Expect Tresiba to Have Much Benefit Over Other Longer-Acting Insulins
- Don't Convert Doses When Switching From Humalog U-100 to U-200
- Think of Toujeo as a More Concentrated Form of Lantus
- Consider Afrezza as an Alternative to Mealtime Insulin Injections
- Treating diabetes in the elderly brings up challenges
- Does it ever make sense to dose extended-release metformin or basal insulin twice daily
- <i>Victoza</i> (VIC-tow-za) will compete with <i>Byetta</i> for type 2 diabetes
- questions about how to switch between insulins
- whether <I>Lantus</I> increases cancer risk
- Is there a maximum dose for <I>Lantus</I> and other insulins
- More type 2s are using insulin
- how to store their injectable diabetes meds